Latest Press Releases

Health News Posted on Friday, January 24, 2025

Premium Press Releases »

King Faisal Specialist Hospital and Research Centre Performs the World's First Robotic-Assisted Artificial Heart Pump Implantation

RIYADH, Saudi Arabia, Jan. 16, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has successfully performed the world’s first robotic-assisted implantation of an artificial heart pump (HeartMate ...

Read More

KFSHRC Launches Precision Medicine Services in Family Medicine Clinics to Enhance Access to the Latest Genetic Tests

RIYADH, Saudi Arabia, Jan. 16, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) has launched precision medicine services within its Family Medicine Clinics, aiming to advance preventive medicine and provide ...

Read More

KFSH&RC Celebrates 25 Scientists Named in Stanford's Top 2% Most-Cited Researchers Worldwide

RIYADH, Saudia Arabia, Jan. 16, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre honored 25 scientists who joined Stanford University's prestigious list, marking them among the 'top 2% most-cited scientists' list ...

Read More

Boehringer provides update on iclepertin Phase III program in schizophrenia

Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with schizophrenia, showing primary and key secondary endpoints were not met. 1–6  Overall, no statistically ...

Read More

Amlan International to Showcase NeutraPath® Research and Calibrin® -Z Technical Demonstrations at International Production and Processing Expo (IPPE) 2025

CHICAGO, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Amlan ® International, a leading provider of mineral-based technologies for animal health, will be exhibiting at the International Production & Processing Expo (IPPE) 2025, held January 28–30, 2025, ...

Read More

KFSHRC Modernizes Biobank Center… Ushering an Era of Personalized Medicine

RIYADH, Saudia Arabia, Jan. 13, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Center (KFSHRC) has announced the modernization of its Biobank Center, marking a significant milestone in healthcare and medical research ...

Read More

KFSHRC’s Study Named Among Top 10 Most Impactful Papers of 2024

RIYADH, Saudia Arabia, Jan. 09, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) has solidified its reputation as a global leader in medical innovation with its study on fully robotic liver ...

Read More

Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific

TAIPEI, Taiwan, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Primo Biotechnology (“Primo”) today announced a strategic partnership with SHINE Technologies, LLC, (“SHINE”) a global leader in nuclear medicine production. The partnership includes a supply ...

Read More

Philips Appoints Jie Xue as Chief Business Leader Precision Diagnosis, Co-leader of the Diagnosis & Treatment segment, and Özlem Fidanci as Chief of International Region

January 9, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the appointment of Jie Xue as Chief Business Leader Precision Diagnosis, and Özlem Fidanci as Chief of ...

Read More

Carterra Ships Its First Ultra Biosensor Platform and Finishes 2024 with Double-digit Growth and Record Revenues

SALT LAKE CITY, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Carterra Inc., the world leader in enabling high-throughput biology, announced today that it has sold and shipped its first Carterra Ultra™ biosensor platform. Announced in September 2024, the ...

Read More

Hummingbird Bioscience Licenses Novel Antibodies to Immunome

SAN FRANCISCO and SINGAPORE, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Hummingbird Bioscience, a precision biotherapeutics company discovering and developing transformative biologics for hard-to-treat diseases, today announced it has granted Immunome, ...

Read More

GUESS Debuts First Ever GUESS BEACH CLUB Takeover of La Luna Beach Club in Queensland

QUEENSLAND, Australia, Jan. 07, 2025 (GLOBE NEWSWIRE) -- GUESS, the iconic American fashion and lifestyle brand renowned for its fashion forward apparel, handbags, footwear and accessories is proud to announce the latest destination of the ...

Read More

Tilray Medical Wins Tender to Supply Luxembourg with Medical Cannabis

NEUMÜNSTER, Germany, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Tilray Medical , a division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), proudly announces that its German subsidiary, Tilray Deutschland GmbH , has secured a tender to supply ...

Read More

iHerb Debuts Digital Wellness Hub to Empower Personal Health Goals

IRVINE, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- iHerb , one of the world's leading online retailers for vitamins, minerals, supplements and other health and wellness products, today announced the launch of its iHerb Wellness Hub , an ...

Read More

How the 5 Word Memory Test Helps Detect Early Signs of Dementia

Affecting millions of people and their families, dementia is an increasing global health issue. Timeliness of intervention, better management, and enhanced quality of life for individuals impacted depend on early diagnosis of dementia. Among the ...

Read More

Press Releases »

Allergan Aesthetics unveils new AA Signature Program and immersive booth at IMCAS World Congress 2025

PR Newswire NORTH CHICAGO, Ill., Jan. 24, 2025 NORTH CHICAGO, Ill., Jan. 24, 2025 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company, the industry leader in aesthetics globally, continues to innovate and elevate the patient journey with ...

Read More

NUS researchers pioneer DNA-tagged gold nanoparticles for targeted cancer treatment

PR Newswire SINGAPORE, Jan. 24, 2025 Using DNA barcoding, the novel technique tracks and optimises gold nanoparticles for precise drug delivery to tumours, advancing cancer therapies that are safer and more effective SINGAPORE, Jan. 24, ...

Read More

Fitness App Market to Grow by USD 101.6 Billion (2025-2029), Driving Health Management Amid Rising Chronic Diseases, Report on AI's Market Impact - Technavio

PR Newswire NEW YORK, Jan. 23, 2025 NEW YORK, Jan. 23, 2025 /PRNewswire/ -- Report on how AI is redefining market landscape - The global fitness app market  size is estimated to grow by USD 101.6 billion from 2025-2029, according to ...

Read More

Premature Ejaculation Treatment Market to Grow by USD 1.53 Billion (2025-2029), Off-Label Drug Efficacy Boosts Revenue, Report with AI-Powered Insights - Technavio

PR Newswire NEW YORK, Jan. 23, 2025 NEW YORK, Jan. 23, 2025 /PRNewswire/ -- Report on how AI is driving market transformation - The global premature ejaculation treatment market  size is estimated to grow by USD 1.53 billion from 2025-2029, ...

Read More

Online Therapy Services Market to Grow by USD 64.09 Billion (2025-2029), Boosted by Smartphone Adoption and Online Service Preference, AI Insights - Technavio

PR Newswire NEW YORK, Jan. 23, 2025 NEW YORK, Jan. 23, 2025 /PRNewswire/ -- Report with the AI impact on market trends - The global online therapy services market size is estimated to grow by USD 64.09 billion from 2025-2029, according to ...

Read More

CG Pharmaceuticals: Progress of U.S. Phase 1b/2 Metastatic Pancreatic Cancer Clinical Trial at the ASCO Gastrointestinal Symposium

PR Newswire ORINDA, Calif., Jan. 23, 2025 ORINDA, Calif., Jan. 23, 2025 /PRNewswire/ -- CG Pharmaceuticals (CG Pharma), a clinical biopharmaceutical company located in the San Francisco Bay Area, was established as an independent entity in ...

Read More

Rakuten Medical Announces Initiation of Global Phase 3 Trial of ASP-1929 Photoimmunotherapy in Combination with Pembrolizumab for First-Line Recurrent Head and Neck Cancer

PR Newswire SAN DIEGO, Jan. 23, 2025 SAN DIEGO, Jan. 23, 2025 /PRNewswire/ -- Rakuten Medical, Inc., a global biotechnology company developing and commercializing precision, cell-targeting Alluminox™ platform-based photoimmunotherapy, today ...

Read More

Los Angeles County Department of Public Health Partners with End Overdose to Address Fentanyl Crisis

PR Newswire LOS ANGELES, Jan. 23, 2025 LOS ANGELES, Jan. 23, 2025 /PRNewswire/ -- The Los Angeles County Department of Public Health, through its Substance Abuse Prevention and Control (SAPC) Bureau, announced a new partnership with End ...

Read More

70+ Key Companies Advancing in Dry Age-Related Macular Degeneration Clinical Trial Therapeutic Space | DelveInsight

PR Newswire LAS VEGAS, Jan. 23, 2025 Dry macular degeneration is a common eye disorder among people aged above 50 years. It causes blurred or reduced central vision due to thinning of the macula. The macula is the part of the retina ...

Read More

EXUMA Biotech Announces Phase 1 Results for its Autologous HER2 Directed, Tumor Metabolism Regulated (TMR) CAR-T Product at ASCO GI 2025

PR Newswire WEST PALM BEACH, Fla., Jan. 23, 2025 No dose-limiting toxicities, severe adverse events, or on-target off-tumor toxicities across all dose cohorts Deep and durable response observed in gastroesophageal cancer EXUMA now ...

Read More

Bell Let's Talk thanks everyone for participating in Canada's 15th annual national day for mental health conversation and action

Canada NewsWire MONTRÉAL, Jan. 23, 2025 MONTRÉAL, Jan. 23, 2025 /CNW/ - Bell Let's Talk Day 2025 put a spotlight on Canada's youth mental health crisis by featuring six mental health organizations that are working every day to provide mental ...

Read More

Gene Transfer Technologies Market to Hit US$5.93 Billion by 2029 with 9.7% CAGR | MarketsandMarkets™

PR Newswire DELRAY BEACH, Fla., Jan. 23, 2025 DELRAY BEACH, Fla., Jan. 23, 2025 /PRNewswire/ -- The global gene transfer technologies market, valued at US$3.63 billion in 2023, is forecasted to grow at a robust CAGR of 9.7%, reaching US$3.73 ...

Read More

Study Published in Journal of Cardiothoracic and Vascular Anesthesia Finds Accuryn Monitoring System Detects Acute Kidney Injury (AKI) in Cardiac Surgery Patients 33 Hours Earlier than Standard Serum Creatine Criteria

PR Newswire HAYWARD, Calif., Jan. 23, 2025 Advanced monitoring technology is critical as the Centers for Medicare & Medicaid Services (CMS) will begin requiring hospitals to report all incidences of AKI as a key indicator of patient safety ...

Read More

Mental Health Apps Market is expected to generate a revenue of USD 17.5 Billion by 2031, Globally, at 19.6% CAGR: Verified Market Research®

PR Newswire LEWES, Del., Jan. 23, 2025 Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive report on the, "Mental Health Apps Market Size and ...

Read More

Complete Breast Care Joins ARSA, Expanding Access to Comprehensive Breast Cancer Care

PR Newswire PLANO, Texas, Jan. 23, 2025 The partnership increases availability to advanced breast cancer treatment and surgical services. PLANO, Texas, Jan. 23, 2025 /PRNewswire-PRWeb/ -- Specialized breast oncology practice Complete ...

Read More

American Liver Foundation and the United States Department of Veterans Affairs and Veteran Health Administration Partner to help Veterans at risk or living with Liver Disease

PR Newswire FAIRFIELD, N.J., Jan. 23, 2025 FAIRFIELD, N.J.  , Jan. 23, 2025 /PRNewswire/ -- Today, American Liver Foundation (ALF) and the U.S. Department of Veterans Affairs (VA) and Veteran Health Administration (VHA) are excited to ...

Read More

Preeclampsia Foundation Launches GAP--SPIRIN: a creative intervention for Black maternal health

PR Newswire NEW YORK, Jan. 23, 2025 GAP—SPIRIN gets low-dose aspirin to those most at risk to help close the maternal health gap in preeclampsia NEW YORK, Jan. 23, 2025 /PRNewswire/ -- In recognition of January 23rd as Maternal Health ...

Read More

Stealth BioTherapeutics Announces PDUFA Action Date Extension for Elamipretide to Treat Patients with Barth Syndrome

PR Newswire NEEDHAM, Mass., Jan. 23, 2025 – New PDUFA Action Date of April 29, 2025, Allows FDA Additional Time to Complete Review –  – Follows Positive FDA Advisory Committee Meeting Vote Concluding that Elamipretide is Effective for ...

Read More

Genprex Announces First Patient Dosed in Phase 2 Expansion Portion of Acclaim-3 Clinical Study of Reqorsa® Gene Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer

PR Newswire AUSTIN, Texas, Jan. 23, 2025 Expects to Complete Enrollment of First 25 Patients in Phase 2 Expansion Study During Second Half of 2025 for Interim Analysis Acclaim-3 Study Has FDA Orphan Drug and Fast Track Designations ...

Read More

Traws Pharma Announces Completion of Phase I Studies with Tivoxavir Marboxil, a Single Dose Oral Investigational Drug for the Treatment and Prevention of H5N1 Bird Flu

PR Newswire NEWTOWN, Pa., Jan. 23, 2025 Phase I completed in healthy volunteers with pharmacokinetic data supporting dosing for both therapeutic and further development for bird flu prevention NEWTOWN, Pa., Jan. 23, 2025 /PRNewswire/ -- ...

Read More

IDEXX Announces Groundbreaking Cancer Dx Panel with Affordable Early Detection Test for Canine Lymphoma

PR Newswire WESTBROOK, Maine, Jan. 23, 2025 Panel expansion planned over the next three years to cover the majority of canine cancer cases, transforming cancer detection and supporting earlier intervention WESTBROOK, Maine, Jan. 23, 2025 ...

Read More

HG Doctors Exposes Humana's Misconduct, Calls for Immediate Action to Protect Patients

PR Newswire BROWARD COUNTY, Fla., Jan. 23, 2025 Hernando Giraldo MD, Inc.has filed a motion for injunctive relief against Humana Inc., exposing a series of alleged unethical practices that jeopardize patient care and community trust. HG ...

Read More

Findings from pivotal nipocalimab Phase 3 study in a broad antibody positive population of people living with generalized myasthenia gravis (gMG) published in The Lancet Neurology

PR Newswire SPRING HOUSE, Pa., Jan. 23, 2025 The first FcRn blocker to demonstrate sustained disease control over 24 weeks in antibody positive adult patients: anti-AChR+, anti-MuSK+, anti-LRP4+ Nipocalimab demonstrated a sustained ...

Read More

First Breakthrough Study Highlights Superiority of MatriDerm® in Wound Healing

PR Newswire BILLERBECK, Germany, Jan. 23, 2025 MatriDerm® by MedSkin Solutions Dr. Suwelack AG Proven to Enhance Cell Activity, Reduce Inflammation, and Deliver Better Wound Healing Outcomes in Research Study BILLERBECK, Germany, Jan. ...

Read More

Senior Living Market to Grow by USD 130.9 Billion (2025-2029), Driven by Aging Baby Boomer Population, Report Highlights AI Impact on Market Trends - Technavio

PR Newswire NEW YORK, Jan. 23, 2025 NEW YORK, Jan. 23, 2025 /PRNewswire/ -- Report on how AI is redefining market landscape - The global senior living market size is estimated to grow by USD 130.9 billion from 2025-2029, according to ...

Read More

AI to assist nurses: New research project reveals the potential of technology in healthcare

PR Newswire ESPOO, Finland, Jan. 23, 2025 ESPOO, Finland, Jan. 23, 2025 /PRNewswire/ -- In many countries, the social welfare sector is struggling with enormous cost-cutting pressures, labour shortage and the growing demand for its services. ...

Read More

Kelun-Biotech's Product Tagitanlimab Approved for Marketing in Second Indication in Combination with Cisplatin and Gemcitabine For the First-line Treatment of Patients with recurrent or metastatic NPC

PR Newswire CHENGDU, China, Jan. 23, 2025 CHENGDU, China, Jan. 23, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company received marketing authorization in China from National ...

Read More

Cadonilimab (PD-1/CTLA-4) Phase III Data for First Line Treatment of Advanced Gastric Cancer Published in Nature Medicine

PR Newswire HONG KONG, Jan. 22, 2025 HONG KONG, Jan. 22, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that the prestigious medical journal Nature Medicine published the results of the company's ...

Read More

Chronic Heart Failure Market to Observe Stunning Growth at a CAGR of 10% by 2034 Owing to Strong Uptake of Entresto and approved SGLT2 Inhibitors along with Emergence of New Class of Therapies | DelveInsight

PR Newswire LAS VEGAS, Jan. 22, 2025 Several leading classes of therapies are exploring diverse mechanisms of action to treat CHF, including SGLT2 inhibitors, cardiac myosin activators, myeloperoxidase inhibitors, mineralocorticoid receptor ...

Read More

Tuberculosis Clinical Trial Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

PR Newswire LAS VEGAS, Jan. 22, 2025 The high and growing incidence of tuberculosis (TB) cases globally, especially in high-burden countries, is a major driver for both the treatment drugs and diagnostics markets. TB remains a significant ...

Read More
More Press Releases

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.